Quality control of the graft in autologous transplantation

Abstract

Hematopoietic stem cell transplantation (HSCT) has been rapidly expanding worldwide over the last twenty years for a broad spectrum of indications. In 2010, more than 50,000 first HSC transplants have been conducted of which 43% were allogeneic and 57% autologous. The majority of stem cell products are derived from bone marrow (BM), peripheral blood (PB) and cord blood (CB)..